Lindahl advised Karolinska Development AB in connection with the recent SEK 437 million financing of Karolinska Development’s portfolio company, Aprea AB. It is the largest private financing to date of a Karolinska Development portfolio company; and it is also one of the largest financings of a private life-science company in Sweden in the last ten years. The investment group was led by specialist life-science investors VERSANT Ventures and 5AM Ventures (both from the US), but Sectoral Asset Management (Canada) and HealthCap (Sweden) also participated.
Lindahl advised Karolinska Development through Anders Moberg (partner leading the transaction), Jonas Westerberg (partner, IP) and Jonathan Söderkvist. Johan Hessius is the partner responsible for Karolinska Development at Lindahl.
Karolinska Development's press release is available here.